NASDAQ:TWST Twist Bioscience (TWST) Stock Price, News & Analysis $147.83 +8.06 (+5.77%) As of 12:22 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Twist Bioscience Stock (NASDAQ:TWST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Twist Bioscience alerts:Sign Up Key Stats Today's Range$134.94▼$147.8850-Day Range$116.10▼$205.0052-Week Range$23.30▼$219.71Volume907,778 shsAverage Volume1.72 million shsMarket Capitalization$9.27 billionP/E RatioN/ADividend YieldN/APrice Target$143.67Consensus RatingHold Company Overview Twist Bioscience Corporation is a biotechnology company that develops and manufactures synthetic DNA and related products for life sciences research. The company uses a proprietary silicon-based platform to produce high-quality DNA at scale, supporting applications in synthetic biology, drug discovery and development, agriculture, and academic and industrial research. Its offerings include synthetic genes, oligonucleotides, gene fragments, variant libraries, and antibody discovery products. Twist also provides next-generation sequencing preparation solutions, including target-enrichment panels and other tools designed to help researchers analyze genetic material. These products are used by pharmaceutical and biotechnology companies, academic institutions, and other research organizations. Founded in 2013 and headquartered in South San Francisco, California, Twist Bioscience serves customers in the United States and international markets. The company was founded by Emily M. Leproust, who serves as its chief executive officer and has led the business since its early development.AI Generated. May Contain Errors. Read More Twist Bioscience Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks40th Percentile Overall ScoreTWST MarketRank™: 2.01753220879 of 5 starsTwist Bioscience scored higher than 40% of companies evaluated by MarketBeat, and ranked 647th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingTwist Bioscience has received a consensus rating of Hold. The company's average rating score is 2.46, and is based on no strong buy ratings, 8 buy ratings, 3 hold ratings, and 2 sell ratings.Upside/DownsideThe consensus price target for Twist Bioscience is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageTwist Bioscience has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Twist Bioscience's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Twist Bioscience are expected to grow in the coming year, from ($2.12) to ($1.56) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Twist Bioscience is -66.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Twist Bioscience is -66.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTwist Bioscience has a P/B Ratio of 18.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Twist Bioscience's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted17.39% of the float of Twist Bioscience has been sold short.Short Interest Ratio / Days to CoverTwist Bioscience has a short interest ratio ("days to cover") of 3.83, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Twist Bioscience has recently decreased by 15.50%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTwist Bioscience does not currently pay a dividend.Dividend GrowthTwist Bioscience does not have a long track record of dividend growth. News and Social Media3.4 / 5News Sentiment0.40 News SentimentTwist Bioscience has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Twist Bioscience this week, compared to 6 articles on an average week.Search Interest19 people have searched for TWST on MarketBeat in the last 30 days. This is an increase of 73% compared to the previous 30 days.MarketBeat Follows6 people have added Twist Bioscience to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Twist Bioscience insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $93,768,202.00 in company stock.Percentage Held by Insiders3.08% of the stock of Twist Bioscience is held by insiders.Percentage Held by InstitutionsTwist Bioscience has minimal institutional ownership at this time.Read more about Twist Bioscience's insider trading history. Receive TWST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TWST Stock News HeadlinesTwist Bioscience Corporation (TWST)4 hours ago | finance.yahoo.comIs Twist Bioscience (TWST) Quietly Becoming Core Infrastructure for AI-Driven Biofoundry Platforms?October 14, 2026 | uk.finance.yahoo.comBuffett's Final Warning: "The Dollar Is Going to Hell"Do not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Alphabet about $4.1 trillion. Microsoft about $3.8 trillion. So what would it take to repeat Nvidia's run? A 100x gain from here puts Nvidia near $550 trillion. Nothing in history has ever been worth that. Big money in Nvidia has already been made. By the people who bought it years ago. But that does not mean the AI boom is finished. It means the opportunity has moved underneath it... to the layer every AI company has to pay to use.October 20 at 1:00 AM | Decentralized Masters (Ad)Twist Bioscience (NASDAQ:TWST) Stock: Insider Adam Laponis Sells 2,462 SharesOctober 14, 2026 | insidertrades.comThese 3 stocks are crushing the magnificent seven this year -- are they still buys?October 12, 2026 | msn.comInsider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells $919,378.20 in StockOctober 8, 2026 | insidertrades.comTwist Bioscience (NASDAQ:TWST) Stock: Insider Emily Leproust Sells 655 SharesOctober 6, 2026 | insidertrades.comTwist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 5,203 Shares of Company StockSeptember 26, 2026 | insidertrades.comSee More Headlines TWST Stock Analysis - Frequently Asked Questions How have TWST shares performed this year? Twist Bioscience's stock was trading at $31.72 at the start of the year. Since then, TWST stock has increased by 366.8% and is now trading at $148.0680. How were Twist Bioscience's earnings last quarter? Twist Bioscience Corporation (NASDAQ:TWST) announced its earnings results on Monday, August, 3rd. The company reported ($0.56) earnings per share for the quarter, missing analysts' consensus estimates of ($0.51) by $0.05. The firm's revenue for the quarter was up 23.2% compared to the same quarter last year. Read the conference call transcript. When did Twist Bioscience IPO? Twist Bioscience (TWST) raised $75 million in an initial public offering on Wednesday, October 31st 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Cowen acted as the underwriters for the IPO and Allen & Company and Baird were co-managers. Who are Twist Bioscience's major shareholders? Top institutional investors of Twist Bioscience include Moody National Bank Trust Division (0.02%), SteelPeak Wealth LLC (0.01%), Abel Hall LLC (0.01%) and Green Alpha Advisors LLC (0.01%). Insiders that own company stock include Emily M Leproust, William Banyai, Patrick John Finn, Paula Green, Adam Laponis, Dennis Cho, Robert F Werner, Melissa A Starovasnik, Robert Chess and Jan Johannessen. View institutional ownership trends. How do I buy shares of Twist Bioscience? Shares of TWST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Twist Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Twist Bioscience investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), CrowdStrike (CRWD), CRISPR Therapeutics (CRSP), Palantir Technologies (PLTR) and Block (XYZ). Company Calendar Last Earnings8/03/2026Today10/20/2026Next Earnings (Estimated)11/13/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 TWST's financial health is in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:TWST CIK1581280 Webwww.twistbioscience.com Phone(800) 719-0671FaxN/AEmployees979Year Founded2013Price Target and Rating Average Price Target for Twist Bioscience$143.67 High Price Target$215.00 Low Price Target$41.00 Potential Upside/Downside-0.9%Consensus RatingHold Rating Score (0-4)2.46 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($2.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$77.67 million Net Margins-31.66% Pretax Margin-31.46% Return on Equity-28.64% Return on Assets-19.94% Debt Debt-to-Equity Ratio0.03 Current Ratio2.67 Quick Ratio2.38 Sales & Book Value Annual Sales$376.57 million Price / Sales24.14 Cash FlowN/A Price / Cash FlowN/A Book Value$7.84 per share Price / Book18.49Miscellaneous Outstanding Shares62,710,000Free Float60,776,000Market Cap$9.09 billion OptionableOptionable Beta2.19 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:TWST) was last updated on 10/20/2026 by MarketBeat.com Staff. From Our PartnersYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredFox News: Wall Street Can Seize Your RetirementFox News reported that under current law, legal title to most stocks and bonds sits with a central institution...Monetary Gold | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
